headshot photo of Dr. Viet-Huong Nguyen

Dr. Viet-Huong Nguyen

Assistant Professor, Pharmacy Practice
School of Pharmacy
Expertise: Epilepsy; Stroke; Genetics; Neuropharmacology; Epidemiology
Office Location: Rinker Health Science Campus 221
Phone: 714-516-5417
Education:
University of Southern California, Bachelor of Arts
University of California, Los Angeles, Master of Public Health
University of Southern California, Master of Science
University of California, San Francisco, Doctor of Pharmacy

Biography

Dr. Nguyen received her Bachelor of Arts degree in Biology and Classics with an emphasis in Literature and Mythology from the University of Southern California in 2001.  She went on to receive her Master of Science degree in Cell and Neurobiology from the University of Southern California in 2003, where she studied molecular signaling pathways of the central nervous system.  She received her Doctor of Pharmacy degree from the UCSF School of Pharmacy in 2007.  While at UCSF, she began to apply her neuroscience background to clinical and translational research and was awarded a fellowship grant from the American Foundation of Pharmaceutical Education (AFPE) to study the role of drug transporters and pharmacogenetics in drug resistant epilepsy.  She completed a general practice pharmacy residency as well as an additional two-year specialty practice residency/fellowship in Neurology at the VA Greater Los Angeles Healthcare System (VAGLAHS), where she expanded her research in pharmacogenetics and drug resistance to include mechanisms of pharmacoresistance in status epilepticus.  In 2014, she received her Master of Public Health degree in Epidemiology from UCLA with a research emphasis in study design and genetic epidemiology. 

Prior to joining CUSP, Dr. Nguyen served as the Clinical Pharmacist Specialist in Neurology at the VAGLAHS’s Epilepsy Center of Excellence.  She also served as the Stroke Pharmacist/ Coordinator for the Stroke program at VAGLAHS and was responsible for the implementation of numerous innovative pharmacy services, including the development of an Anti-Epileptic Drug Response Phenotype Database as well as the development of pharmacist-managed Epilepsy and Stroke Prevention clinics with expanded scope of practice.  Additionally, she was integral to the development of the PGY2 specialty pharmacy practice residency in Neurology at VAGLAHS, the first neurology pharmacy residency eligible for ASHP accreditation.  She was also an Adjunct Assistant Professor of Pharmacy Practice at USC School of Pharmacy for 8 years, assisting with the curriculum for epilepsy and stroke and has mentored/precepted over 80 students and residents from VAGLAHS, USC, UCSF, UOP, and Western University Schools of Pharmacy.

Research Interests:

Dr. Nguyen’s research interests are in the areas of epilepsy and stroke.  She is interested in the pharmacogenetics of drug response and resistance in epilepsy and is a member of GENESS, an international consortium of clinicians and scientists whose mission is to identify genes causing genetic epilepsies including Juvenile Myoclonic Epilepsy, Childhood Absence Epilepsy, and Lafora Epilepsy,in order to develop curative therapies for these disorders.  Dr. Nguyen also participates in stroke outcomes/health services research and has authored numerous peer-reviewed publications, book chapters, and meeting abstracts in epilepsy, stroke, and neuropharmacy.

Recent Creative, Scholarly Work and Publications

Rao NM, Wu MJ, Nguyen V-H, Dergalust S, Aramian A, Minassian G, Siddiqui U, McCreary M, Neil WP, Wallis RA, Saver JL. Multicenter Analysis of Stroke Risk Factor Treatment. Stroke. 2018;49(Suppl 1):WP281.
Discua D, Duron RM, Martinez IE, Nguyen V-H, Patterson C, Bailey JN, Tanaka M, Ochoa A, Jara Prado A, Alonso M, López Ruiz M, Medina M, Guilhoto L, Yacubian E, Silva R, Arias C, Delgado-Escueta A. A New Database Platform for Clinical and Genetic Investigation of Epilepsies and the New ILAE Classification. Neurology. 2018;90(Suppl 15):P2.261.
Tanaka M, Martinez-Juarez I, Duron RM, Nguyen V-H, Ochoa A, Jara-Prado A, Alonso M, Lopez-Ruiz M, Medina M, Guilhoto L, Yacubian M, Silva R, Patterson C, Bailey J, Delgado-Escueta A. Autophagy in Juvenile Myoclonic Epilepsy (JME). Neurology. 2018;90(Suppl 15):P2.275.
Durón RM, Arias C, Martínez-Juárez I, Patterson C, Bailey J, Tanaka M, Ochoa A, Jara-Prado A, Alonso M, Medina M, Nguyen V-H, Delgado-Escueta AV. Analyzing Phenotypes Using Artificial Intelligence Tools in Subgroups of Absence and Myoclonic Epilepsies. Neurology, 2018;90(Suppl 15):P.2.344.
Bailey JN, de Nijs L, Bai D, Suzuki T, Miyamoto H, Tanaka M, Patterson C, Lin YC, Medina MT, Alonso ME, Serratosa JM, Durón RM, Nguyen V-H, Wight JE, Martínez-Juárez IE, Ochoa A, Jara-Prado A, Guilhoto L, Molina Y, Yacubian EM, Lopez-Ruiz M, Inoue Y, Kaneko S, Hirose S, Osawa M, Oguni H, Fujimoto S, Grisar T, Yamakawa K, Lakaye B, Delgado-Escueta AV. Intestinal Cell Kinase heterozygous variants in Juvenile Myoclonic Epilepsy. New England Journal of Medicine. 2018;378:1018-1028.
Nguyen V-H, Baca CB, Chen JJ, Rogers SA. (2017). Epilepsy. In JT Dipiro, R Talbert, GC Yee, GR Matzke, & BG Wells (Eds.), Pharmacotherapy: A pathophysiologic approach, Tenth Edition (pp. xx-xx). New York, NY: McGraw Hill Education.
Cook AM, Liang N, Nguyen V-H. (2017) Seizures in Critical Care. In G Brophy (Eds), Neuropharmacotherapy in Critical Care, First Edition (pp.xx-xx). New Brunswick, NJ: Rutgers University Press.
Nguyen V-H, Serratosa JM, Gonzales B, Genton P, Michelucci R, Sinha S, Chandra S, Beydoun A, Arabi M, Kecmanovic M, Whitehouse W, Martinez-Juarez IM, Guilhoto L, Salas-Puig J, Ben-Menachem E, Goldsmith D, Duron RM, Medina MT, Bailey JN, Gentry M, Minassian B, Delgado-Escueta AV. Updates to the Lafora Epilepsy Cure Initiative (LECI) Clinical Center: Development of a data collection tool for measurement of Lafora Epilepsy Disease Progression. Epilepsia. 2017;58(Suppl 5):S194-S195.